spacer
home > pmps > spring 2017 > breathing new life into asthma care
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Breathing New Life into Asthma Care

Smart inhalers represent a convergence of several market forces, technology and trends that are poised to change asthma care and improve outcomes. They are part of an overall smart device trend in mHealth focused at the multibillion dollar asthma industry. One of the biggest culprits of poor patient outcomes in asthma care is taking a reactive rather than proactive approach to treatment, and poor adherence of care plans among patients.

Why Smart Inhalers?

The technology around these devices can offer a number of benefits to both the patient and the healthcare provider, such as making it easier to remember to take prevention medicine and report symptoms, which can lead to improved disease self-management and adherence rates. Other benefits include their ability to collect actionable data and patients being able to identify their own patterns. Sixty-seven percent of patients do not take their inhalers correctly. With smart sensors built into these devices, the patient is told if they have shaken it correctly or not.

The sensors can also detect the quality of inhalation, which is very important when it comes to judging the effectiveness of the medication. Collection of key data, recognising patterns and potential aggravators to severe asthma attacks can help reduce costly readmissions and result in improved disease management as well as adherence rates. In the future, a convergence of trends and technologies will put smart inhalers and their accompanying data at the epicentre of managing asthma care. To this end, some companies

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
An engineer at heart and entrepreneur by trade, Ali Moiyed is founder and Chief Executive Officer of Aerobit Health. Living with asthma himself, he launched the digital healthcare company in July 2016.
spacer
Ali Moiyed
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Horizon Discovery and Fulcrum Therapeutics Form Collaboration for Novel CRISPR-Based Target Discovery in Genetic Diseases

The collaboration will utilize Horizonís world-leading CRISPR-based screening platform to identify novel targets for regulating gene expression.
More info >>

White Papers

Running Better Trials Taking an Intelligent Monitoring Approach

Bioclinica

When it comes to implementing a risk-based monitoring program, it is not just about reducing monitoring visits and doing less Source Document Verification (SDV). Itís about bringing together your people, a solid process, and the right technology to run a better trial. Success with risk-based monitoring requires the ability to make sense of the thousands, if not millions, of data points captured by multiple disparate sources in a clinical trial. With the sheer volume of data generated on a daily basis comes complexity. How does one make sense of it all? Information overload burdens even the most experienced study teams who struggle to understand which data matters most and what it means.
More info >>

 
Industry Events

CPhI Worldwide 2017

24-26 October 2017, Messe Frankfurt, Germany

CPhI Worldwide, together with co-located events ICSE, InnoPack, P-MEC and FDF, hosts more than 42,000 visiting pharma professionals over three days. 2,500+ exhibitors from 153 countries gather at the event to network and take advantage of more than 150 free industry seminars. The exhibition covers every sector of the pharmaceutical market under one roof.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement